131 related articles for article (PubMed ID: 23803024)
21. Long-term effects of mass screening for neuroblastoma in infancy.
Sawada T; Matsumura T; Kawakatsu H; Sugimoto T; Kuroda H; Hosoi H; Michihata T; Saida T; Hino T
Am J Pediatr Hematol Oncol; 1991; 13(1):3-7. PubMed ID: 2029075
[TBL] [Abstract][Full Text] [Related]
22. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
23. Incidence, ocular manifestations, and survival in children with neuroblastoma: a population-based study.
Smith SJ; Diehl NN; Smith BD; Mohney BG
Am J Ophthalmol; 2010 Apr; 149(4):677-682.e2. PubMed ID: 20149339
[TBL] [Abstract][Full Text] [Related]
24. [Neuroblastoma in Costa Rica: the experience with 76 cases treated at the Hospital Nacional de Niños].
Lobo-Sanahuja F; Carranza A; García I; Barrantes M; Camacho-Morales A
Bol Med Hosp Infant Mex; 1991 Jun; 48(6):426-33. PubMed ID: 1910558
[TBL] [Abstract][Full Text] [Related]
25. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
[TBL] [Abstract][Full Text] [Related]
26. [Neuroblastoma with bone marrow invasion. A multicenter study. Work Group of the Spanish Society of Pediatric Surgery].
Jiménez Alvarez C; Bregante Ucedo JI; Costa Borrás E; Martínez Ibáñez V; Mulet Ferragut JF; Obiols Arderius P; Queizán de la Fuente A; Rollán Villamarín V; Sainz Samitier A; Torres Piedra C
Cir Pediatr; 1994 Oct; 7(4):164-6. PubMed ID: 7865359
[TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma: a single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors.
Lau L
Pediatr Hematol Oncol; 2002 Mar; 19(2):79-89. PubMed ID: 11881792
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastoma: a 32-year population-based study--implications for screening.
Huddart SN; Muir KR; Parkes S; Mann JR; Stevens MC; Raafat F
Med Pediatr Oncol; 1993; 21(2):96-102. PubMed ID: 8433685
[TBL] [Abstract][Full Text] [Related]
29. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
[TBL] [Abstract][Full Text] [Related]
30. A single center clinical analysis of children with high-risk neuroblastoma.
Tian X; Cao Y; Wang J; Yan J; Tian Y; Li Z; Wang H; Duan X; Jin Y; Zhao Q
Oncotarget; 2017 May; 8(18):30357-30368. PubMed ID: 28423674
[TBL] [Abstract][Full Text] [Related]
31. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma.
Shah S; Ravindranath Y
Indian J Pediatr; 1998; 65(5):691-705. PubMed ID: 10773924
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis.
Coldman AJ; Fryer CJ; Elwood JM; Sonley MJ
Cancer; 1980 Oct; 46(8):1896-1901. PubMed ID: 7427894
[TBL] [Abstract][Full Text] [Related]
34. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
Dinh T; Truong B; Matthay KK; DuBois SG
J Pediatr Hematol Oncol; 2017 Mar; 39(2):108-113. PubMed ID: 27820129
[TBL] [Abstract][Full Text] [Related]
36. Neuroblastoma: outcome over a 14 year period from a tertiary care referral centre in India.
Agarwala S; Mandelia A; Bakhshi S; Srinivas M; Bajpai M; Gupta AK; Gupta DK; Bhatnagar V
J Pediatr Surg; 2014 Aug; 49(8):1280-5. PubMed ID: 25092090
[TBL] [Abstract][Full Text] [Related]
37. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
38. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma.
Han W; Wang HM
World J Gastroenterol; 2015 Jul; 21(25):7929-32. PubMed ID: 26167095
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma: report on a 21-year experience.
Massad M; Slim MS; Mansour A; Dabbous I; Firzli S; Issa P
J Pediatr Surg; 1986 May; 21(5):388-91. PubMed ID: 3712188
[TBL] [Abstract][Full Text] [Related]
40. Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors.
Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
Nat Commun; 2021 Sep; 12(1):5309. PubMed ID: 34493726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
